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Background: Nitroglycerin (NTG) challenge during head-up tilt-table testing (HUTT) is often utilized to
determine the etiology of unexplained vascular syncope. However, conﬂicting results concerning nitrate-
induced hemodynamic changes during HUTT have been reported. The purpose of this study was to assess
the determinants of presyncopal symptoms during NTG-stimulated HUTT.
Methods: We evaluated 40 patients with suspected vasovagal syncope. Beat-to-beat changes in blood
pressure, heart rate (HR), cardiac index (CI), and systemic vascular resistance (SVR) during HUTT were
measured with thoracic impedance cardiography and a plethysmographic ﬁnger arterial pressure
monitoring device.
Results: None of the 40 patients complained of presyncopal symptoms during passive HUTT. However,
after the administration of NTG 28 patients showed presyncopal symptoms (NTGþ group) and the
remaining 12 patients did not (NTG– group). HR, CI, and the stroke index did not signiﬁcantly differ
between the two groups, whereas mean arterial pressure and SVR were signiﬁcantly lower in the
NTGþ group.
Conclusions: Presyncopal symptoms during NTG-stimulated HUTT are SVR mediated, not cardiac output
mediated. This study challenges the conventional idea of a decrease in cardiac output mediated by NTG
as the overriding cause of presyncopal symptoms during HUTT.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. All rights reserved.
1. Introduction
Syncope is a syndrome in which a relatively short period of
temporary and self-limited loss of consciousness is caused by a tra-
nsient diminution of blood ﬂow to the brain. The prevalence of syn-
cope in the general population is reported to vary from 15% to 23%
[1]. Vasovagal syncope is a transient loss of consciousness caused by
systemic arterial hypotension resulting from reﬂex vasodilatation
and/or bradycardia. It is the most common cause of syncope in the
general population and is responsible for one-ﬁfth of all syncope
episodes [2].
The diagnosis of vasovagal syncope is usually based on a com-
bination of careful history taking, clinical examination, and a surface
electrocardiogram to exclude cardiac and non-cardiac causes of
syncope [3,4]. When the etiology of syncope is uncertain, head-up
tilt-table testing (HUTT) is commonly used to reproduce symptoms
in patients with suspected vasovagal syncope [3,5]. Nitroglycerin
(NTG) challenge during HUTT is often utilized to determine the
etiology of unexplained syncope [5,6]. NTG may facilitate syncope
through various pathways, but the precise mechanism of its con-
tribution to syncope remains unclear [7].
Traditionally, venodilation and the venous pooling of blood into
the low extremities and splanchnic and mesenteric vasculature
along with the subsequent reduction of left ventricular preload
have been regarded as the main hemodynamic effects of NTG,
while arterial dilatation is thought to play a smaller role [8,9].
Some studies showed that sublingual NTG provokes a cardiac
output-mediated vasovagal response that is not preceded by a fall
in systemic vascular resistance (SVR) [10,11]. However, conﬂicting
results concerning NTG-induced hemodynamic changes have been
reported. Several studies revealed decreases in SVR without a
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marked change in cardiac output (CO) or heart rate (HR) during
NTG administration [12].
The purpose of this study was to assess the determinants of
presyncopal symptoms and to compare hemodynamic patterns
between patients with and without presyncopal symptoms during
NTG-stimulated HUTT.
2. Materials and methods
2.1. Study population and head-up tilt-table test protocol
We evaluated 42 consecutive patients admitted to our hospital
for syncope or presyncope between November 2012 and March
2013. All patient medical histories included at least one syncopal
episode suspected to have been caused by vasovagal response in
the last year. The exclusion criteria were an age of less than 18
years, a history of cardiovascular disease, carotid sinus syndrome,
any disease that might affect the autonomic nervous system, and
the use of medication that might affect the cardiovascular system.
HUTT was performed in accordance with current guidelines by
a trained nurse [4]. Testing was performed between 9:00 AM and
1:00 PM in a quiet, temperature-controlled (23 1C) room [13].
Patients refrained from caffeine-containing products, smoking,
and heavy meals for at least 6 h and from alcohol for at least 24 h
prior to the test. After 10 min of supine rest, the table was tilted to 701
(passive tilt phase). If presyncopal symptoms did not occur during
20 min of passive tilt, 0.25 mg of NTG was administered sublingually
and testing continued for another 20 min (NTG phase).
Presyncopal symptoms were deﬁned as light-headedness, nau-
sea, blurred vision, pallor, and sweating in association with
hypotension and/or bradycardia. Impending syncope was halted
by means of tilt-back. Patients were divided into two groups
according to whether or not they experienced presyncopal symp-
toms after NTG administration.
2.2. Hemodynamic measurements
Hemodynamic parameters were determined with a thoracic
bioimpedance cardiography (ICG) device (Niccomo™, Medis, Ilme-
nau, Germany), which records continuous changes in body electric
impedance during the cardiac cycle. After rubbing and cleaning
the skin with alcohol to achieve as low as possible skin-to-
electrode impedance, two sensors with gel pads were carefully
placed on each side of the thorax along the mid-axillary line and
the two remaining sensors were placed on each side of the neck
just above the clavicle. An alternating current of 1.5 mA (85 kHz)
was applied, and the ICG signal was continuously displayed on the
screen along with the electrocardiographic signal. Stroke volume
(SV, mL) was computed every single heart beat and averaged over
15 heart beats to take physiological respiratory variations into
account. The stroke index (SI, min/m2) was calculated based on SV
and body surface area. CO (L/min) was the product of the
estimated SV and HR. The cardiac index (CI, L/min/m2) was then
calculated based on the SV, HR, and body surface area. Raw data
were analyzed ofﬂine and all ICG measurements were performed
with a single monitor using PC-version 1.9 of the Niccomo soft-
ware. Beat-to-beat changes in systolic and diastolic arterial blood
pressures were measured at every heart beat from the ﬁnger
arterial pressure wave form by a plethysmographic method via the
Finometer (Finometers PRO, Finapres Medical System, Nether-
lands) and averaged. mean arterial pressure (MAP) was the true
integral of the arterial pressure wave over one beat divided by the
corresponding beat interval. HR (bpm) was obtained continuously
by ﬁve-lead electrocardiographic monitoring. SVR (dyn s/cm5) was
calculated as the MAP at heart level divided by the computed CO.
2.3. Study periods
1. Supine baseline: beat-to-beat data of the last 5 min in the
supine position before head-up tilting were averaged.
2. After tilt: beat-to-beat data from the 5 min in the 701 head-up
tilt position to the last minute before NTG administration were
averaged (early steady-state circulatory adjustment). The ﬁrst
5 min after head-up tilting were not included in order to avoid
transition phenomena.
3. After NTG administration: beat-to-beat data of the last 5 min
after NTG administration were averaged. If presyncopal symp-
toms occurred, the last 5 min before tilt back or counter-
maneuvers were averaged.
2.4. Statistical analysis
Data were reported as mean and standard deviation for con-
tinuous variables and as percentages for categorical variables. For
the testing of signiﬁcance, between-group comparisons of contin-
uous variables were analyzed by independent t-tests. Comparisons
of categorical variables were generated by the Pearson χ2 test.
Statistical comparisons were performed using SPSS, version 15.0
software (SPSS Inc.). All tests were 2-sided, and the results were
considered statistically signiﬁcant at a p-value o0.05.
3. Results
3.1. Study population
Of 42 patients, 2 were excluded because presyncopal symp-
toms were noted prior to the administration of NTG. The 28 (70%)
patients who showed presyncopal symptoms after NTG adminis-
tration were classiﬁed as the NTGþ group. Another 12 patients
who had negative results were classiﬁed as the NTG group.
Table 1 lists comparative differences between the two groups. The
NTGþ and NTG groups did not differ signiﬁcantly with regard to
age, gender distribution, body mass index (BMI), smoking status,
and history of hypertension or diabetes. The number of previous
syncopal episodes was not different between the two groups
(NTGþ vs. NTG; 2.672.2 vs. 2.271.4; p¼0.5). The presence of
prodromal symptoms before syncope was similar between the two
groups (NTGþ vs. NTG–; 70% vs. 75%; p¼1.0) and nausea with
sweating was the most frequently observed symptom. The occur-
rence of associated injury was similar in the NTGþ and
NTG– groups (NTGþ vs. NTG–; 15% vs. 17%; p¼1.0).
Table 1
Baseline characteristics of the study population.
Variables NTGþ group
(n¼28)
NTG group
(n¼12)
p-Value
Age (years) 38715 43718 0.17
Male (n, %) 11 (39%) 8 (66%) 0.21
Body mass index (kg/m2) 23.874 24.373.7 0.18
Smoking (n, %) 4 (14.3%) 3 (25%) 0.13
Hypertension (n, %) 4 (14.3%) 2 (16.7%) 0.64
Diabetes (n, %) 1 (3.6%) 1 (8.3%) 0.51
Syncopal episodes (n) 2.672.2 2.271.4 0.5
Presence of prodromal
symptoms (n, %)
19 (70.4%) 9 (75%) 1.0
Presence of associated injury
(n, %)
4 (14.8%) 2 (16.7%) 1.0
Data are expressed as the mean7SD or number (percentage).
Body mass index (BMI)¼Weight (kg)/Length2 (m2).
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In the NTGþ group, HUTT after NTG administration was
aborted after 3.571.8 min due to presyncopal symptoms and a
progressive fall of blood pressure.
3.2. Hemodynamic data in the supine position before tilting
In the supine position before tilting, ﬁnger systolic pressure
was higher in the NTG– group than in the NTGþ group (122717
vs. 110715 mm Hg; p¼0.06). None of the remaining circulatory
parameters including HR, LVET, CI, SI, and SVR differed signiﬁ-
cantly between the two groups in the supine position before
tilting (Table 2). All patients were normotensive, with an average
MAP of 86713 mm Hg. In the supine position before tilting, the
estimated CI was 2.970.5 and 2.870.7 l/min/m2 (p¼0.27) and
the estimated SVR was 11947296 and 12287416 dyn s/cm5
(p¼0.32) in NTGþ and NTG groups, respectively.
3.3. Hemodynamic data during passive tilting
In the 70-degree head-up tilt position, all patients were asympto-
matic. Both ﬁnger and brachial systolic and diastolic pressures as well
as MAP were signiﬁcantly decreased in the NTGþ group, along with a
compensatory rise in HR in order to maintain CI (Table 2, Fig. 1A–C).
In both groups, a fall in SI occurred upon moving from the supine to
the tilt position (% fall of SI; NTGþ vs. NTG; 29% vs. 21%; p¼0.30).
SVR was not signiﬁcantly different between the two groups during
passive tilting (NTGþ vs. NTG; 1,1867346 vs. 1,2037287; p¼
0.90; Table 2, Fig. 2A and B).
3.4. Hemodynamic parameters after NTG administration
On average, peak HR in the entire cohort reached 2 min prior to
the onset of presyncopal symptoms and exceeded 100 bpm in 19
patients. Peak HR was not different between the NTGþ and NTG
groups (107726 vs. 103713; p¼0.54). Minute averages of circula-
tory data after NTG administration are shown in Table 3. The changes
in circulatory variables during the last 5 min before tilt-back in both
study groups are presented in Figs. 1 and 2. In all patients, a further
reduction of MAP along with an increase in HR was observed, with
signiﬁcant differences between the NTGþ and NTG groups
(66715 vs. 82713 mmHg; p o0.001; Fig. 1A and B). During the
last minute before tilt-back, all patients had marked hypotension,
with a meanMAP of 60715 mmHg. The mean HR in the last minute
prior to tilt-back was 101723 bpm (range 32–158 bpm). HR fell
below 60 bpm in 5 (18%) of the 28 patients in the NTGþ group. The
estimated CI was 2.470.6 and 2.670.5 l/min/m2 in the NTGþ
Table 2
Hemodynamic parameters in the supine position and during head-up tilt.
Supine position Passive tilt
NTGþ (n¼28) NTG (n¼12) p NTGþ (n¼28) NTG (n¼12) p
Blood pressure (mmHg)
Finger systolic 110715 122717 0.06 90712 107721 0.03
Finger diastolic 58711 61714 0.42 5279 6079 0.03
Brachial systolic 115714 124718 0.10 10171 124721 0.001
Brachial diastolic 60711 63714 0.47 55712 6679 0.05
Mean arterial 78712 88721 0.25 71713 88711 0.005
Heart rate (bpm) 67711 6779 0.87 82717 70714 0.04
LVET (ms) 308747 308752 0.99 271741 248743 0.16
Cardiac index (l/min/m2) 2.970.5 2.870.7 0.62 2.670.6 2.670.4 0.62
Stroke index (ml/m2) 46711 42711 0.27 3579 3576 0.54
SVR (dyn s/cm5) 11947296 12287416 0.32 11867346 12037287 0.90
SVRI (dyn s/cm5/m2) 6617226 6617223 0.99 6427256 647 7169 0.36
LVET, left ventricular ejection time; SVR, systemic vascular resistance; SVRI, systemic vascular resistance index.
Fig. 1. Changes in the average mean arterial pressure (MAP) (A), heart rate (HR) (B),
and cardiac index (CI) (C) during three phases: supine baseline, passive tilt, and
after nitroglycerin (NTG) administration. Particularly for the post-NTG administra-
tion phase, parameters during last 5 min before tilt-back are presented. MAP
signiﬁcantly decreased in the NTGþ group along with a compensatory rise in HR in
order to maintain CI.
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group and NTG group, respectively (p¼0.50). SI was further
decreased after NTG administration in all patients, with a tendency
toward a more pronounced decrease in the NTG– group (NTGþ vs.
NTG; 32710 vs. 2676; p¼0.09). SVR after NTG administration
was signiﬁcantly lower in the NTGþ group than in the NTG group
(10797268 vs. 12547340; p¼0.03).
4. Discussion
The precise mechanism by which nitrates increase the sensitivity
of HUTT is not yet understood. We therefore tried to evaluate hem-
odynamic changes in subjects with nitrate-induced presyncope.
Our data suggest that systemic hypotension in a vasovagal response
induced by nitrates is the result of a decrease in SVR without a
signiﬁcant change of CO.
Small doses of nitrates have traditionally been considered
potent venodilators, leading to decreased ventricular preload and
CO with a lesser impact on arterial resistance, and this effect of
nitrate compounds has generally been assumed to be the main
mechanism of nitrate-induced vasovagal syncope [8]. Several
studies that used pulsations of indirect ﬁnger arterial pressure to
show a reduced CO in subjects with presyncope during nitrate-
stimulated HUTT support this concept [9–11]. However, Koole et al.
found no evidence of increased venous pooling during nitrate-
stimulated tilt testing in patients with a history of vasovagal syn-
cope using a radionuclide technique [14]. Moreover, two reports
that used thoracic bioimpedance and echocardiography did not
reveal a decreased CO after NTG administration [12,15].
Consistent with our results, a recent study also suggested that
the determinant of nitrate-induced presyncopal symptoms dec-
reased SVR by means of thoracic bioimpedance [16]. These res-
earchers examined the inﬂuence of body position on the response
to NTG, and found that SVR decreased to a greater extent in sub-
jects with presyncope than in the non-syncope group regardless of
whether NTG was administrated in the supine position or upright
position. They also observed a greater increase in aortic reﬂection
time and decrease in pulse pressure in response to NTG in the
presyncope group, which suggested decreased arterial resistance.
In this study, we evaluated beat-to-beat hemodynamic changes
with ICG during 3 phases of HUTT: in the supine position, in the
upright position, and during NTG administration. While passive tilting
was insufﬁcient to reproduce presyncopal symptoms, a marked
decrease in MAP was observed in the NTGþ group and an HR
increment that may be explained by the baroreﬂex mechanism was
observed. After the administration of NTG, a more profound decrease
in MAP with presyncopal symptoms was observed in the NTGþ
group along with a minimal increase in HR. The relatively small
increment of HR in the NTGþ group suggests that NTG can inﬂuence
the autonomic response. Previous literature revealed that nitrate-
induced vasovagal syncope is related not only to a vasodilatory effect
but also to baroreceptor-mediated stimulation of autonomic tone and
neurohormonal activation [7,13]. NTG can stimulate sympathetic tone
and induce vasovagal syncope by increasing cardiac contractility and
subsequently triggering intraventricular pressure receptors, leading to
the Bezold–Jarisch reﬂex [7]. However, we did not assess the effect of
NTG on autonomic nervous tone and are unable to evaluate its
contribution to presyncopal symptoms. Further studies of the role of
baroreﬂex activity in vasovagal syncope are needed [13].
We found no difference in CI after NTG administration between the
NTGþ and NTG– groups. This seems at variance with traditional
concepts, according to which a decrease in venous return and sub-
sequent decrease in CO are responsible for syncope. Notably, in our
study, a steep fall in SVR, reﬂecting decreased peripheral arteriolar
tone, was observed only in the NTGþ group, while CI was unchanged.
These ﬁndings are strong evidence for the contribution of a decrease in
SVR to nitrate-stimulated presyncopal symptoms, suggesting that
arterial dilatation, instead of venodilation, may play a critical role in
reduced SVR.
ICG, which simply and non-invasively measures changes in
thoracic impedance generated by ﬂuctuating blood volumes dur-
ing the cardiac cycle, allows for the calculation of stroke volume,
CO, and other derived parameters[17]. In recent years, the accuracy
of ICG has been greatly improved by the advent of real-time beat-
to-beat blood pressure monitoring, obtaining results equivalent to
those of conventional invasive methods [17–19].
4.1. Limitations
There were several limitations in this study. First, the study
population was small and further study is needed in a larger
population. Second, the NTGþ group included thinner patients
Fig. 2. Changes in stroke index (SI) (A) and systemic vascular resistance (SVR) (B).
SVR was signiﬁcantly decreased in the NTGþ group after NTG administration,
while SI was preserved.
Table 3
Hemodynamic parameters after NTG administration.
NTGþ group
(n¼28)
NTG group
(n¼12)
p-Value
Blood pressure (mmHg)
Finger systolic 62712 93715 o0.001
Finger diastolic 38710 60713 o0.001
Brachial systolic 92720 123723 o0.001
Brachial diastolic 53714 71711 0.001
Mean arterial 66715 82713 o0.001
Heart rate (bpm) 84732 99712 0.14
LVET (ms) 209723 226748 0.341
Cardiac index (l/min/m2) 2.470.6 2.670.5 0.50
Stroke index (ml/m2) 32710 2676 0.09
SVR (dyn s/cm5) 10797268 12547340 0.03
SVRI (dyn s/cm5/m2) 6127193 6837261 0.04
LVET, left ventricular ejection time; SVR, systemic vascular resistance; SVRI,
systemic vascular resistance index.
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and a greater number of females. There were several reports that
investigated the relationship between HUTT and gender. Wu et al.
reported that the results of HUTT did not differ between males and
females [20]. Pietrucha et al. also reported that there was no
signiﬁcant relationship between gender and the results of HUTT
regardless of pharmacologic stressor [21]. However, the current
study found that patients with presyncopal symptoms tended to
be female and have lower blood pressure and lower body mass
index, although this difference was not signiﬁcant. Further study is
needed to elucidate hemodynamic differences according to body
physics and gender.
5. Conclusion
In conclusion, presyncopal symptoms during nitrate-stim-
ulated tilt testing were explained by decreased SVR, while CO
and SI remained unchanged.
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